Verve Therapeutics Stock Forward View
| VERVDelisted Stock | USD 11.13 0.00 0.00% |
Verve Stock outlook is based on your current time horizon.
The value of RSI of Verve Therapeutics' share price is above 70 at this time. This entails that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Verve, making its price go up or down. Momentum 71
Buy Stretched
Oversold | Overbought |
Using Verve Therapeutics hype-based prediction, you can estimate the value of Verve Therapeutics from the perspective of Verve Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Verve Therapeutics on the next trading day is expected to be 11.98 with a mean absolute deviation of 0.49 and the sum of the absolute errors of 29.66. Verve Therapeutics after-hype prediction price | USD 11.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Verve |
Verve Therapeutics Additional Predictive Modules
Most predictive techniques to examine Verve price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Verve using various technical indicators. When you analyze Verve charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Verve Therapeutics Naive Prediction Price Forecast For the 5th of February
Given 90 days horizon, the Naive Prediction forecasted value of Verve Therapeutics on the next trading day is expected to be 11.98 with a mean absolute deviation of 0.49, mean absolute percentage error of 0.53, and the sum of the absolute errors of 29.66.Please note that although there have been many attempts to predict Verve Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Verve Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Verve Therapeutics Stock Forecast Pattern
| Backtest Verve Therapeutics | Verve Therapeutics Price Prediction | Research Analysis |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Verve Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Verve Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.4683 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4863 |
| MAPE | Mean absolute percentage error | 0.0712 |
| SAE | Sum of the absolute errors | 29.6619 |
Predictive Modules for Verve Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Verve Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Verve Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Verve Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Verve Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Verve Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Verve Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Verve Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Verve Therapeutics' historical news coverage. Verve Therapeutics' after-hype downside and upside margins for the prediction period are 11.13 and 11.13, respectively. We have considered Verve Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Verve Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Verve Therapeutics is based on 3 months time horizon.
Verve Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Verve Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Verve Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Verve Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.13 | 11.13 | 0.00 |
|
Verve Therapeutics Hype Timeline
Verve Therapeutics is at this time traded for 11.13. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Verve is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Verve Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 11.13. About 95.0% of the company outstanding shares are owned by institutional investors. The book value of Verve Therapeutics was at this time reported as 5.33. The company recorded a loss per share of 2.11. Verve Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be any time. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.Verve Therapeutics Related Hype Analysis
Having access to credible news sources related to Verve Therapeutics' direct competition is more important than ever and may enhance your ability to predict Verve Therapeutics' future price movements. Getting to know how Verve Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Verve Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALBO | Albireo Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GRCL | Gracell Biotechnologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CBIO | Crescent Biopharma | 0.00 | 0 per month | 0.00 | (0.12) | 7.58 | (6.58) | 22.50 | |
| VECT | VectivBio Holding AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EQRX | EQRx Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PSTX | Poseida Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ETHZ | ETHZilla | 0.00 | 0 per month | 0.00 | (0.35) | 6.49 | (12.25) | 29.16 | |
| CDMO | Avid Bioservices | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HARP | Harpoon Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Verve Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verve Therapeutics stock to make a market-neutral strategy. Peer analysis of Verve Therapeutics could also be used in its relative valuation, which is a method of valuing Verve Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Verve Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Verve Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verve Therapeutics shares will generate the highest return on investment. By undertsting and applying Verve Therapeutics stock market strength indicators, traders can identify Verve Therapeutics entry and exit signals to maximize returns.
Story Coverage note for Verve Therapeutics
The number of cover stories for Verve Therapeutics depends on current market conditions and Verve Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Verve Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Verve Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Verve Therapeutics Short Properties
Verve Therapeutics' future price predictability will typically decrease when Verve Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Verve Therapeutics often depends not only on the future outlook of the potential Verve Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verve Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 84.7 M | |
| Cash And Short Term Investments | 524.3 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Verve Stock
If you are still planning to invest in Verve Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Verve Therapeutics' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |